Skip to main content

Column Group IV GP, LP

In the past year, 2 open-market purchase filings worth $39.2M and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$39.2M
2 filings
Sold
–
0 filings
Net
+$39.2M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Column Group IV GP, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

EIKN Eikon Therapeutics, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 8, 2026 (view filing)4:33 PM ETSep 35 daysSvennilson Peter and 7 others10% OwnerPPurchase+89.2K$11.56+$1.03MNew position89.2K after
Feb 9, 2026 (view filing)9:19 PM ETFeb 63 daysSvennilson Peter and 7 others10% OwnerPPurchase+2.12M$18.00+$38.1MNew position1.32M after3 lots

NGM NGM Biopharmaceuticals Inc

10% Owner22 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2023 (view filing)4:30 PM ETNov 15-162 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+22.6K$0.6852+$15.5K+2.4%949.9K after2 lotsDuplicate filing
Feb 1, 2023 (view filing)4:50 PM ETJan 30-312 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+184.3K$5.00+$921.1K+24.8%927.2K after2 lotsDuplicate filing
Jan 25, 2023 (view filing)4:35 PM ETJan 232 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+9.90K$5.00+$49.5K+1.4%743.0K afterDuplicate filing
Jan 23, 2023 (view filing)4:22 PM ETJan 19-204 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+38.1K$5.00+$190.6K+5.5%733.1K after2 lotsDuplicate filing
Jan 17, 2023 (view filing)4:34 PM ETJan 125 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+5.38K$4.95+$26.6K+0.8%694.9K afterDuplicate filing
Jan 12, 2023 (view filing)4:37 PM ETJan 10-112 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+309.1K$4.79+$1.48M+81.2%689.5K after2 lotsDuplicate filing
Dec 14, 2022 (view filing)4:29 PM ETDec 122 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+300$4.98+$1.49K+0.1%380.5K afterDuplicate filing
Nov 23, 2022 (view filing)4:17 PM ETNov 21-222 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+40.3K$5.00+$201.6K+11.9%380.2K after2 lotsDuplicate filing
Nov 7, 2022 (view filing)4:20 PM ETNov 3-44 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+139.1K$4.92+$684.4K+69.3%339.8K after2 lotsDuplicate filing
Oct 31, 2022 (view filing)5:19 PM ETOct 274 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+76.9K$4.86+$373.6K+62.1%200.7K afterDuplicate filing

See all 22 trades at NGM

RAPT RAPT Therapeutics, Inc.

10% Owner3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 27, 2022 (view filing)4:29 PM ETMay 252 daysColumn Group II, LP and 4 others10% OwnerPPurchase+1.90K$12.45+$23.7K+4.7%42.2K after2 lotsDuplicate filing
May 25, 2022 (view filing)4:20 PM ETMay 23-242 daysColumn Group II, LP and 4 others10% OwnerPPurchase+26.6K$12.19+$323.7K+170.5%42.1K after4 lotsDuplicate filing
May 12, 2022 (view filing)5:29 PM ETMay 102 daysColumn Group II, LP and 4 others10% OwnerPPurchase+1.25M$10.67+$13.3MNew position41.3K after2 lotsDuplicate filing